{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:34:44Z","timestamp":1791851684961,"version":"4.3.4"},"reference-count":100,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthritis &amp; Rheumatology"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To provide guidance to rheumatology providers on the management of adult rheumatic disease in the context of the coronavirus disease 2019 (<jats:styled-content style=\"fixed-case\">COVID<\/jats:styled-content>\u201019) pandemic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A task force, including 10 rheumatologists and 4 infectious disease specialists from North America, was convened. Clinical questions were collated, and an evidence report was rapidly generated and disseminated. Questions and drafted statements were reviewed and assessed using a modified Delphi process. This included 2 rounds of asynchronous anonymous voting by e\u2010mail and 3 webinars with the entire panel. Task force members voted on agreement with draft statements using a 1\u20139\u2010point numerical scoring system, and consensus was determined to be low, moderate, or high based on the dispersion of votes. For approval, median votes were required to meet predefined levels of agreement (median values of 7\u20139, 4\u20136, and 1\u20133 defined as agreement, uncertainty, or disagreement, respectively) with either moderate or high levels of consensus.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The task force approved 77 initial guidance statements: 36 with moderate and 41 with high consensus. These were combined, resulting in 25 final guidance statements.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These guidance statements are provided to promote optimal care during the current pandemic. However, given the low level of available evidence and the rapidly evolving literature, this guidance is presented as a \u201cliving document,\u201d and future updates are anticipated.<\/jats:p><\/jats:sec>","DOI":"10.1002\/art.41301","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T18:52:41Z","timestamp":1588186361000},"page":"1241-1251","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID\u201019 Pandemic: Version 1"],"prefix":"10.1002","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0897-2272","authenticated-orcid":false,"given":"Ted R.","family":"Mikuls","sequence":"first","affiliation":[{"name":"University of Nebraska Medical Center, Omaha, Nebraska and VA Nebraska\u2013Western Iowa Health Care System  Omaha Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0591-2976","authenticated-orcid":false,"given":"Sindhu R.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Toronto Western Hospital Mount Sinai Hospital, and University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6148-610X","authenticated-orcid":false,"given":"Liana","family":"Fraenkel","sequence":"additional","affiliation":[{"name":"Berkshire Health Systems, Pittsfield, Massachusetts, and Yale University  New Haven Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben J.","family":"Arasaratnam","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center  Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey R.","family":"Baden","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital  Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie L.","family":"Bermas","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center  Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winn","family":"Chatham","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Cohen","sequence":"additional","affiliation":[{"name":"Metroplex Clinical Research Center  Dallas Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Costenbader","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital  Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Gravallese","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital  Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre C.","family":"Kalil","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center  Omaha"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Weinblatt","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital  Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Winthrop","sequence":"additional","affiliation":[{"name":"Oregon Health and Science University  Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Mudano","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Turner","sequence":"additional","affiliation":[{"name":"American College of Rheumatology  Atlanta Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth G.","family":"Saag","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017"},{"key":"e_1_2_6_3_1","unstructured":"Arthritis foundation. URL:https:\/\/www.arthritis.org\/."},{"key":"e_1_2_6_4_1","unstructured":"GHLF Creakyjoints. URL:https:\/\/creakyjoints.org\/."},{"key":"e_1_2_6_5_1","unstructured":"Global Healthy Living Foundation. URL:https:\/\/www.ghlf.org\/."},{"key":"e_1_2_6_6_1","first-page":"59","volume-title":"The RAND\/UCLA appropriateness method","author":"Brook R","year":"1994"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806253382607"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462300012022"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-4-200808190-00003"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530080048040"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-8_Part_2-200110161-00003"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.017"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6775"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.112"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2014.03.009"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6942(03)00041-X"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32831bc0c4"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/xcdary"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.054"},{"key":"e_1_2_6_22_1","first-page":"1","article-title":"Novel 2019 coronavirus SARS\u2010CoV\u20102 (COVID\u201019): an overview for emergency clinicians","volume":"17","author":"Giwa AL","year":"2020","journal-title":"Pediatr Emerg Med Pract"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25829"},{"key":"e_1_2_6_24_1","unstructured":"Centers for Disease Control and Prevention.How to protect yourself & others.2020. URL:https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/prevent-getting-sick\/prevention.html."},{"key":"e_1_2_6_25_1","unstructured":"Centers for Disease Control and Prevention.What to do if you are sick. May2020. URL:https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/if-you-are-sick\/steps-when-sick.html."},{"key":"e_1_2_6_26_1","unstructured":"American College of Rheumatology.COVID\u201019 practice and advocacy resources. May2020. URL:https:\/\/www.rheumatology.org\/Announcements\/COVID-19-Practice-and-Advocacy#Telehealth."},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.08.003"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15082"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0318"},{"key":"e_1_2_6_31_1","unstructured":"American Heart Association.Patients taking ACE\u2010i and ARBs who contract COVID\u201019 should continue treatment unless otherwise advised by their physician. March2020. URL:https:\/\/newsroom.heart.org\/news\/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician."},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.317134"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.07.007"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181173"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8034"},{"key":"e_1_2_6_36_1","unstructured":"US Food and Drug Administration.FDA advises patients on use of non\u2010steroidal anti\u2010inflammatory drugs (NSAIDs) for COVID\u201019. March2020. URL:https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19."},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.03.005"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.0950"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"key":"e_1_2_6_40_1","unstructured":"National Institute for Health and Care Excellence.COVID\u201019 rapid guideline: managing symptoms (including at the end of life) in the community. April2020. URL:https:\/\/www.nice.org.uk\/guidance\/ng163."},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30057-1"},{"key":"e_1_2_6_42_1","article-title":"Clinical characteristics and treatment of patients infected with COVID\u201019 in Shishou, China","author":"Qin X","year":"2020","journal-title":"Lancet"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.25756"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30304-4"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.07.006"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2395-8"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22628"},{"key":"e_1_2_6_48_1","first-page":"6222","article-title":"Herpes zoster in patients with systemic lupus erythematosus: clinical features, complications and risk factors","volume":"14","author":"Chen D","year":"2017","journal-title":"Exp Ther Med"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.08.004"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90277-V"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010015"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem076"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa237"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949"},{"key":"e_1_2_6_56_1","unstructured":"US Food and Drug Administration.Coronavirus (COVID\u201019) update: daily roundup. March2020. URL:https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-daily-roundup-march-30-2020\"."},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0282-0"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2020.01047"},{"key":"e_1_2_6_59_1","unstructured":"US Food and Drug Administration.FDA drug shortages. April2020. URL:https:\/\/www.accessdata.fda.gov\/scripts\/drugshortages\/dsp_ActiveIngredientDetails.cfm?AI=Hydroxychloroquine+Sulfate+Tablets%26st=c%26tab=tabs-4%26panels=0."},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22837"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319851558"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000030"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101173240303"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1191\/096120398678919778"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1105"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-016-0062-9"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1574806"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes305"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.11.015"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61704-9"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-016-0609-5"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.151043"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1692"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq242"},{"key":"e_1_2_6_75_1","first-page":"962","article-title":"Does methotrexate increase the risk of varicella or herpes zoster infection in patients with rheumatoid arthritis? A systematic literature review","volume":"30","author":"Zhang N","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.146"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40189"},{"key":"e_1_2_6_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.51"},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61811-X"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205726"},{"key":"e_1_2_6_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61751-1"},{"key":"e_1_2_6_82_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213271"},{"key":"e_1_2_6_83_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.128637"},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319860579"},{"key":"e_1_2_6_85_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207838"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102523"},{"key":"e_1_2_6_87_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1492-4"},{"key":"e_1_2_6_88_1","doi-asserted-by":"publisher","DOI":"10.3390\/v5051250"},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.034983-0"},{"key":"e_1_2_6_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30132-8"},{"key":"e_1_2_6_91_1","unstructured":"National Institutes of Health.Therapeutic options for COVID\u201019 currently under investigation. April2020. URL:https:\/\/covid19treatmentguidelines.nih.gov\/therapeutic-options-under-investigation\/."},{"key":"e_1_2_6_92_1","unstructured":"XuX HanM LiT SunW WangD FuB et al.Effective treatment of severe COVID\u201019 patients with tocilizumab. February2020. URL:https:\/\/www.ser.es\/wp-content\/uploads\/2020\/03\/TCZ-and-COVID-19.pdf."},{"key":"e_1_2_6_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102537"},{"key":"e_1_2_6_94_1","unstructured":"ClinicalTrials.gov. National Library of Medicine.Efficacy and safety of emapalumab and anakinra in reducing hyperinflammation and respiratory distress in patients with COVID\u201019 infection. April2020. URL:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04324021."},{"key":"e_1_2_6_95_1","unstructured":"ClinicalTrials.gov. National Library of Medicine.Anti\u2010IL6 treatment of serious COVID\u201019 disease with threatening respiratory failure (TOCIVID). April2020. URL:https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04322773."},{"key":"e_1_2_6_96_1","unstructured":"ClinicalTrials.gov. National Library of Medicine.Tocilizumab vs CRRT in management of cytokine release syndrome (CRS) in COVID\u201019 (TACOS). April2020. URL:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04306705."},{"key":"e_1_2_6_97_1","unstructured":"ClinicalTrials.gov. National Library of Medicine.Evaluation of the efficacy and safety of sarilumab in hospitalized patients with COVID\u201019. April2020. URL:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04315298."},{"key":"e_1_2_6_98_1","unstructured":"ClinicalTrials.gov. National Library of Medicine.Treatment of moderate to severe coronavirus disease (COVID\u201019) in hospitalized patients. April2020. URL:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04321993."},{"key":"e_1_2_6_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.02.003"},{"key":"e_1_2_6_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.03.013"},{"key":"e_1_2_6_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0418-0"}],"container-title":["Arthritis &amp; Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.41301","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/art.41301","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.41301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:26:41Z","timestamp":1759948001000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/art.41301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":100,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1002\/art.41301"],"URL":"https:\/\/doi.org\/10.1002\/art.41301","archive":["Portico"],"relation":{},"ISSN":["2326-5191","2326-5205"],"issn-type":[{"value":"2326-5191","type":"print"},{"value":"2326-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"assertion":[{"value":"2020-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}